PRESCIENT THERAPEUTICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.041 AUD | -4.65% |
|
-10.87% | -33.87% |
| 03-25 | Transcript : Prescient Therapeutics Limited - Special Call | |
| 02-23 | Prescient Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Chart calendar Prescient Therapeutics Limited
b6e41c08eb4c9df48476d90ad.OB4hKneMc-KOa3J_ITfn-nZUAGn24Ca2CqgJFQo1oNM.UkoSZBK-JZvsCAQ8UE-rlkIiRSGRhBfzUMBzbT598YN9KFB4Qc1K0voFMw~d3f96c21e085bb64ceea312d2d0692be
Upcoming events on Prescient Therapeutics Limited
Past events on Prescient Therapeutics Limited
| 10/04/2024 | Cutaneous Lymphomas World Congress |
| 22/02/2024 23:14 | Q2 2024 Earnings Release |
| 31/01/2024 00:52 | December 2023 Sales and Revenue Release - Activities Report |
| 08/12/2023 | American Society of Hematology Meeting |
| 16/11/2023 01:00 | Annual General Meeting |
| 30/10/2023 22:38 | September 2023 Sales and Revenue Release - Activities Report |
| 09/10/2023 | Cell & Gene Meeting on the Mesa Conference |
| 25/08/2023 00:07 | Q4 2023 Earnings Release |
| 22/08/2023 | Reach Markets The Insider Meet the CEO Conference |
| 03/08/2023 05:00 | TechKnow Invest Conference |
| 27/07/2023 00:07 | June 2023 Sales and Revenue Release - Activities Report |
| 24/02/2023 02:38 | Q2 2023 Earnings Release |
| 09/02/2023 | Investor Meeting |
| 09/02/2023 01:00 | Investor Meeting |
| 25/01/2023 02:45 | December 2022 Sales and Revenue Release - Activities Report |
| 28/11/2022 | Annual General Meeting |
| 04/10/2022 02:00 | Investor Meeting |
| 29/09/2022 | Investor Meeting |
| 27/09/2022 03:00 | Investor Meeting |
| 21/09/2022 03:00 | Investor Meeting |
Annual results
| Fiscal Period | June | 2019 | 2020 |
|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1,72 0,00 - | 1,15 |
|
EBITDA Million AUD | Released Forecast Spread | -3,82 -4,90 22.03% | -4,49 |
|
EBIT Million AUD | Released Forecast Spread | -3,82 -4,90 22% | -4,49 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -3,80 -3,50 -8.49% | -3,32 |
|
Net income Million AUD | Released Forecast Spread | -3,80 -3,50 -8.49% | -3,32 |
|
EPS AUD | Released Forecast Spread | -0,02 -0,01 -55% | -0,01 |
| Announcement Date | 25/08/19 | 25/08/20 |
Quarterly results
| Fiscal Period | June | 2020 S1 | 2020 S2 |
|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,00 0,00 - | 0,51 |
|
EBITDA Million AUD | Released Forecast Spread | -2,23 -3,70 39.82% | -2,16 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -1,70 -2,30 26.21% | -1,62 |
|
Net income Million AUD | Released Forecast Spread | -1,70 -2,30 26.21% | -1,62 |
|
EPS AUD | Released Forecast Spread | 0,00 -0,01 57% | 0,00 |
| Announcement Date | 27/02/20 | 25/08/20 |
More events
Past sector events for Prescient Therapeutics Limited
| 10/05/2024 12:00 | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 09/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 09/05/2024 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 09/05/2024 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 21:10 | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | OMNIAB, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- PTX Stock
- Calendar Prescient Therapeutics Limited
